Swedish Orphan Biovitrum AB (BIOVF)
47.48
0.00 (0.00%)
USD |
OTCM |
May 15, 16:00
Swedish Orphan Biovitrum EPS Diluted (Quarterly) : 0.4127 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BONESUPPORT HOLDING AB | 0.0875 |
| BioInvent International AB | -0.1982 |
| Hansa Biopharma AB | -0.2111 |
| BioArctic AB | -0.0106 |
| Egetis Therapeutics AB | 0.00 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 144.19M |
| Revenue (Quarterly) | 785.93M |
| Total Expenses (Quarterly) | 641.74M |
| Enterprise Value | 18.32B |
| Gross Profit Margin (Quarterly) | 66.20% |
| Profit Margin (Quarterly) | 18.35% |
| Earnings Yield | 0.61% |
| Operating Earnings Yield | 5.54% |
| Normalized Earnings Yield | 3.834 |